Decrease of miR-202-3p Expression, a Novel Tumor Suppressor, in Gastric Cancer

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Zhao, Yu ^a   Li, Chenglong ^a   Wang, Ming ^a   Su, Liping ^a   Qu, Ying ^a   Li, Jianfang ^a   Yu, Beiqin ^a   Yan, Min ^a   Yu, Yingyan ^a   Liu, Bingya ^a   Zhu, Zhenggang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MIR 133B; MIR 202 3P; PLAKOGLOBIN; PROTEIN BCL 2; TRANSCRIPTION FACTOR GLI1; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN TARGETING; STOMACH CANCER;

AGED; ANIMALS; APOPTOSIS; CARCINOMA; CELL LINE, TUMOR; FEMALE; GAMMA CATENIN; GASTRECTOMY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; HUMANS; MALE; MICE; MICE, NUDE; MICRORNAS; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; RETROVIRIDAE; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR BURDEN;

EID: 84880764250     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069756     Document Type: Article

References (45)

1. Stahlhut Espinosa CE, Slack FJ, (2006) The role of microRNAs in cancer. Yale J Biol Med 79: 131-140.
2. Esquela-Kerscher A, Slack FJ, (2006) Oncomirs- microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269.
3. Cho WC, (2010) MicroRNAs in cancer- from research to therapy. Biochim Biophys Acta 1805: 209-217.
4. Cho WC, (2010) MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int J Biochem Cell Biol 42: 1273-1281.
5. Ohshima K, Inoue K, Fujiwara A, Hatakeyama K, Kanto K, et al. (2010) Let-7 MicroRNA Family Is Selectively Secreted into the Extracellular Environment via Exosomes in a Metastatic Gastric Cancer Cell Line. PLoS One 5.
6. Ribeiro-dos-Santos A, Khayat AS, Silva A, Alencar DO, Lobato J, et al. (2010) Ultra-deep sequencing reveals the microRNA expression pattern of the human stomach. PLoS One 5: e13205.
7. Otsubo T, Akiyama Y, Hashimoto Y, Shimada S, Goto K, et al. (2011) MicroRNA-126 Inhibits SOX2 Expression and Contributes to Gastric Carcinogenesis. PLoS One 6.
8. Liang SL, He LJ, Zhao XD, Miao Y, Gu Y, et al. (2011) MicroRNA Let-7f Inhibits Tumor Invasion and Metastasis by Targeting MYH9 in Human Gastric Cancer. PLoS One 6.
9. Jiang JT, Zheng X, Xu X, Zhou Q, Yan HJ, et al. (2011) Prognostic Significance of miR-181b and miR-21 in Gastric Cancer Patients Treated with S-1/Oxaliplatin or Doxifluridine/Oxaliplatin. PLoS One 6.
10. Li BS, Zhao YL, Guo G, Li W, Zhu ED, et al. (2012) Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection. PLoS One 7: e41629.
11. Crone SG, Jacobsen A, Federspiel B, Bardram L, Krogh A, et al. (2012) microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-kappaB by targeting CARD10 and COPS8 in gastric cancer. Mol Cancer 11: 71.
12. Zhou F, Zhu H, Luo D, Wang M, Dong X, et al. (2012) A functional polymorphism in Pre-miR-146a is associated with susceptibility to gastric cancer in a Chinese population. DNA Cell Biol 31: 1290-1295.
13. Yao Q, Cao Z, Tu C, Zhao Y, Liu H, et al. (2013) MicroRNA-146a acts as a metastasis suppressor in gastric cancer by targeting WASF2. Cancer Lett.
14. Feng R, Chen X, Yu Y, Su L, Yu B, et al. (2010) miR-126 functions as a tumour suppressor in human gastric cancer. Cancer Lett 298: 50-63.
15. Li C, Nie H, Wang M, Su L, Li J, et al. (2012) MicroRNA-409-3p regulates cell proliferation and apoptosis by targeting PHF10 in gastric cancer. Cancer Lett 320: 189-197.
16. Wang M, Li C, Nie H, Lv X, Qu Y, et al. (2012) Down-regulated miR-625 suppresses invasion and metastasis of gastric cancer by targeting ILK. FEBS Lett 586: 2382-2388.
17. Zhang BG, Li JF, Yu BQ, Zhu ZG, Liu BY, et al. (2012) microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN. Oncol Rep 27: 1019-1026.
18. Wang M, Li C, Yu B, Su L, Li J, et al. (2013) Overexpressed miR-301a promotes cell proliferation and invasion by targeting RUNX3 in gastric cancer. J Gastroenterol.
19. Yu BQ, Su LP, Li JF, Cai Q, Yan M, et al. (2012) microrna expression signature of gastric cancer cells relative to normal gastric mucosa. Mol Med Rep 6: 821-826.
20. Peiffer SL, Herzog TJ, Tribune DJ, Mutch DG, Gersell DJ, et al. (1995) Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial cancers. Cancer Res 55: 1922-1926.
21. Lee SH, Davison JA, Vidal SM, Belouchi A, (2001) Cloning, expression and chromosomal location of NKX6B TO 10Q26, a region frequently deleted in brain tumors. Mamm Genome 12: 157-162.
22. Courtens W, Wuyts W, Rooms L, Pera SB, Wauters J, (2006) A subterminal deletion of the long arm of chromosome 10: a clinical report and review. Am J Med Genet A 140: 402-409.
23. Schrauder MG, Strick R, Schulz-Wendtland R, Strissel PL, Kahmann L, et al. (2012) Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection. PLoS One 7: e29770.
24. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070.
25. Zhang Y, Dai Y, Huang Y, Ma L, Yin Y, et al. (2009) Microarray profile of micro-ribonucleic acid in tumor tissue from cervical squamous cell carcinoma without human papillomavirus. J Obstet Gynaecol Res 35: 842-849.
26. Ng EK, Chong WW, Jin H, Lam EK, Shin VY, et al. (2009) Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 58: 1375-1381.
27. Hoffman AE, Liu R, Fu A, Zheng T, Slack F, et al. (2013) Targetome Profiling, Pathway Analysis and Genetic Association Study Implicate miR-202 in Lymphomagenesis. Cancer Epidemiology Biomarkers & Prevention 22: 327-336.
28. Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, et al. (2008) E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 13: 272-286.
29. Pizzimenti S, Ferracin M, Sabbioni S, Toaldo C, Pettazzoni P, et al. (2009) MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidation. Free Radic Biol Med 46: 282-288.
30. Buechner J, Tomte E, Haug BH, Henriksen JR, Lokke C, et al. (2011) Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma. Br J Cancer 105: 296-303.
31. Mitas M, Almeida JS, Mikhitarian K, Gillanders WE, Lewin DN, et al. (2005) Accurate discrimination of Barrett's esophagus and esophageal adenocarcinoma using a quantitative three-tiered algorithm and multimarker real-time reverse transcription-PCR. Clin Cancer Res 11: 2205-2214.
32. Katoh Y, Katoh M, (2005) Hedgehog signaling pathway and gastric cancer. Cancer Biology & Therapy 4: 1050-1054.
33. Ma X, Chen K, Huang S, Zhang X, Adegboyega PA, et al. (2005) Frequent activation of the hedgehog pathway in advanced gastric adenocarcinomas. Carcinogenesis 26: 1698-1705.
34. Xu XF, Guo CY, Liu J, Yang WJ, Xia YJ, et al. (2009) Gli1 maintains cell survival by up-regulating IGFBP6 and Bcl-2 through promoter regions in parallel manner in pancreatic cancer cells. J Carcinog 8: 13.
35. Yoon JW, Kita Y, Frank DJ, Majewski RR, Konicek BA, et al. (2002) Gene expression profiling leads to identification of GLI1-binding elements in target genes and a role for multiple downstream pathways in GLI1-induced cell transformation. J Biol Chem 277: 5548-5555.
36. Zhang YZ, Zhang LH, Gao Y, Li CH, Jia SQ, et al. (2011) Discovery and validation of prognostic markers in gastric cancer by genome-wide expression profiling. World J Gastroenterol 17: 1710-1717.
37. Hafner M, Landthaler M, Burger L, Khorshid M, Hausser J, et al. (2010) Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 141: 129-141.
38. Kinzler KW, Bigner SH, Bigner DD, Trent JM, Law ML, et al. (1987) Identification of an amplified, highly expressed gene in a human glioma. Science 236: 70-73.
39. Lee J, Platt KA, Censullo P, Ruiz i Altaba A, (1997) Gli1 is a target of Sonic hedgehog that induces ventral neural tube development. Development 124: 2537-2552.
40. Ji Z, Mei FC, Xie J, Cheng X, (2007) Oncogenic KRAS activates hedgehog signaling pathway in pancreatic cancer cells. J Biol Chem 282: 14048-14055.
41. Yoo YA, Kang MH, Kim JS, Oh SC, (2008) Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway. Carcinogenesis 29: 480-490.
42. Katoh Y, Katoh M, (2009) Integrative genomic analyses on GLI1: positive regulation of GLI1 by Hedgehog-GLI, TGFbeta-Smads, and RTK-PI3K-AKT signals, and negative regulation of GLI1 by Notch-CSL-HES/HEY, and GPCR-Gs-PKA signals. Int J Oncol 35: 187-192.
43. Stecca B, Ruiz i Altaba A, (2009) A GLI1-p53 inhibitory loop controls neural stem cell and tumour cell numbers. EMBO J 28: 663-676.
44. Li X, Deng W, Nail CD, Bailey SK, Kraus MH, et al. (2006) Snail induction is an early response to Gli1 that determines the efficiency of epithelial transformation. Oncogene 25: 609-621.
45. Ma XL, Sun HI, Wang YS, Huang SH, Xie JW, et al. (2006) Study of Sonic hedgehog signaling pathway related molecules in gastric carcinoma. World Journal of Gastroenterology 12: 3965-3969.